Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Denosumab treatment for osteoporosis can cause hair loss.

JAK inhibitors offer new hope for treating severe alopecia areata.

Mogamulizumab can cause hair loss and skin rashes.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

People with severe hair loss (Alopecia Areata) have different scalp bacteria than healthy people, which might help predict the condition's progress.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Treatment type and patch size affect hair regrowth patterns in alopecia areata.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.